Citadel Group Form 8.3 - Allergan plc (3454L)
April 29 2020 - 10:00AM
UK Regulatory
TIDM0Y7T
RNS Number : 3454L
Citadel Group
29 April 2020
Ap 19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT,
1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note Citadel Group
1)
Company dealt in ALLERGAN PLC
-------------------------------
Class of relevant security Common Stock ISIN IE00BY9D5467
to which the dealings being ------------------------------
disclosed relate (Note 2)
Date of dealing 28 April, 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in
the class of relevant security
dealt in (Note 3)
Long Short
Common Stock ISIN IE00BY9D5467 Number (%) Number (%)
----------------- ----------
(1) Relevant securities 3,133,451 (0.95%) 30 (0.00%)
----------------- ----------
(2) Derivatives (other than
options) 3,465,201 (1.05%) 0 (0.00%)
----------------- ----------
(3) Options and agreements
to purchase/sell 0 (0.00%) 0 (0.00%)
----------------- ----------
Total 6,598,652(2.01%) 30 (0.00%)
----------------- ----------
(b) Interests and short positions in relevant securities
of the company, other than the class dealt in (Note 3)
Long Short
Number (%) Number (%)
---------- ----------
(1) Relevant securities
---------- ----------
(2) Derivatives (other than
options)
---------- ----------
(3) Options and agreements
to purchase/sell
---------- ----------
Total
---------- ----------
Ap 20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of securities Price per unit (Note
Common Stock ISIN IE00BY9D5467 5)
Purchase 400 187.03 USD
-------------------- --------------------
Purchase 200 187.04 USD
-------------------- --------------------
Purchase 220 187.10954545 USD
-------------------- --------------------
Purchase 200 187.13 USD
-------------------- --------------------
Purchase 67 187.28 USD
-------------------- --------------------
Purchase 2,005 187.29630424 USD
-------------------- --------------------
Purchase 70 187.302 USD
-------------------- --------------------
Purchase 58 187.32551724 USD
-------------------- --------------------
Purchase 2,812 187.35 USD
-------------------- --------------------
Purchase 1,498 187.35220294 USD
-------------------- --------------------
Purchase 825 187.38033939 USD
-------------------- --------------------
Purchase 1,737 187.38601612 USD
-------------------- --------------------
Purchase 560 187.4025 USD
-------------------- --------------------
Purchase 326 187.43944785 USD
-------------------- --------------------
Purchase 443 187.47611738 USD
-------------------- --------------------
Purchase 100 187.51 USD
-------------------- --------------------
Purchase 1,148 187.54651568 USD
-------------------- --------------------
Purchase 770 187.59694156 USD
-------------------- --------------------
Purchase 2 187.64 USD
-------------------- --------------------
Purchase 800 187.651875 USD
-------------------- --------------------
Purchase 300 187.67333333 USD
-------------------- --------------------
Purchase 6 187.72 USD
-------------------- --------------------
Purchase 200 187.79 USD
-------------------- --------------------
Sale -267 187.34715356 USD
-------------------- --------------------
Sale -266 187.34834586 USD
-------------------- --------------------
Sale -100 187.38 USD
-------------------- --------------------
Sale -341 187.39709677 USD
-------------------- --------------------
Sale -234 187.39777778 USD
-------------------- --------------------
Sale -788 187.40756345 USD
-------------------- --------------------
Sale -108 187.48203704 USD
-------------------- --------------------
Sale -12,271 187.497413 USD
-------------------- --------------------
Sale -1,507 187.50731254 USD
-------------------- --------------------
Sale -1,430 187.511 USD
-------------------- --------------------
Sale -450 187.51577778 USD
-------------------- --------------------
Sale -262 187.52045802 USD
-------------------- --------------------
Sale -17,729 187.625931 USD
-------------------- --------------------
Sale -449 187.63218263 USD
-------------------- --------------------
Sale -126 187.64857143 USD
-------------------- --------------------
Sale -2,005 187.65785037 USD
-------------------- --------------------
Sale -527 187.65804554 USD
-------------------- --------------------
Sale -100 187.7 USD
-------------------- --------------------
Sale -558 187.7097491 USD
-------------------- --------------------
Sale -2,036 187.7861002 USD
-------------------- --------------------
Sale -10 187.83 USD
-------------------- --------------------
Sale -496 187.84096774 USD
-------------------- --------------------
Sale -6 187.89 USD
-------------------- --------------------
Sale -125 187.9256 USD
-------------------- --------------------
Sale -200 188.145 USD
-------------------- --------------------
Sale -518 188.27027027 USD
-------------------- --------------------
Sale -50 188.4 USD
-------------------- --------------------
Sale -23 188.51826087 USD
-------------------- --------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant Price per unit
e.g. CFD (Note 6) securities (Note 5)
ISIN (Note 7)
(c) Options transactions in respect of existing relevant
securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option money
name, e.g. selling, securities price e.g. date paid/
call option purchasing, to which the American, received
varying etc. option European per unit
relates etc. (Note 5)
(Note 7)
(ii) Exercising
Product name, Number of securities Exercise price per unit
e.g. call option (Note 5)
(d) Other dealings ( including transactions in respect of
new securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note
5)
Ap 21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating
to the voting rights of any relevant securities under any
option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities
to which any derivative referred to on this form is referenced.
If none, this should be stated
None
Is a Supplemental Form 8 attached? NO
(Note 9)
Date of disclosure: 29 April, 2020
Contact name: Katie Bonds
--------------
Telephone number: 020 7645 9700
--------------
If a connected EFM, name of offeree/offeror n/a
with which connected
--------------
If a connected EFM, state nature n/a
of connection (Note 10)
--------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ISEBBGDSRGDDGGC
(END) Dow Jones Newswires
April 29, 2020 10:00 ET (14:00 GMT)
Allergan (LSE:0Y7T)
Historical Stock Chart
From Oct 2024 to Nov 2024
Allergan (LSE:0Y7T)
Historical Stock Chart
From Nov 2023 to Nov 2024
